---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-039443"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T21:44:43.098270+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences enters $10M common stock purchase agreement with Lincoln Park Capital

## Summary
- Lincoln Park commits to buy up to $10M of Enveric common stock over 24 months at the company's discretion.
- Company issued 139,403 commitment shares as consideration for Lincoln Park's commitment.
- Purchase price per share based on market prices; regular purchases up to 25,000 shares per day with potential increases.
- Proceeds to be used for general corporate purposes including R&D, working capital, and possible acquisitions.

## SEC filing metadata
- accession: 0001493152-23-039443
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315223039443/0001493152-23-039443-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315223039443/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-039443
- JSON: https://secwatch.observer/filing/0001493152-23-039443.json
- Plain text: https://secwatch.observer/filing/0001493152-23-039443.txt

## Key facts
- Material Agreements
  Enveric Biosciences, Inc. entered into Purchase Agreement with Lincoln Park Capital Fund, LLC valued at $10.0 million (effective 2023-11-03).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Lincoln Park Capital Fund, LLC
  - Value: $10.0 million
  - Effective: 2023-11-03
  source text: On November 3, 2023, Enveric Biosciences, Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) and a registration rights agreement (the “Registration Rights Agreement”), with Lincoln Park Capital Fund, LLC (“Lincoln Park”), pursuant to which Lincoln Park has committed to purchase up to $10.0 million of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000149315223039443/0001493152-23-039443-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.